Related Experiment Video
Updated: Feb 18, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Crosstalk of LKB1- and PTEN-regulated signals in liver morphogenesis and tumor development
Chengyou Jia1,2, Vivian Medina2, Chenchang Liu2
1Department of Nuclear Medicine, Central Laboratory for Medical Research, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Abstract:
Liver kinase B 1 (LKB1 or STK11) and PTEN (phosphatase and tensin homologue deleted on chromosome 10) are two tumor suppressors that regulate the mTOR signaling pathway. Deletion studies show that loss of either Lkb1 (Lkb ) or Pten (Pten ) leads to liver injury and development of hepatocarcinoma. In this study, we investigated the crosstalk of LKB1 and PTEN loss during tumorigenesis and liver development. We show here that haplo-insufficiency of Lkb1 in the liver leads to advanced tumor development in the Pten null mice (Pten ). Our analysis shows that LKB1 and PTEN interacted with each other in their regulation of fatty acid synthase as well as p21 expression. The combined loss of LKB1 and PTEN (Pten ) also led to the inability to form zonal structures in the liver. The lack of metabolic zonal structures is consistent with the inability of the livers to store glycogen as well as elevated plasma bilirubin and alanine aminotransferase (ALT), indicative of liver dysfunction. These structural and functional defects are associated with cytoplasm distribution of a canalicular membrane protein MRP2 (multidrug resistant protein 2) which is responsible for clearing bilirubin. This observed regulation of MRP2 by LKB1 likely contributed to the lack of cellular polarity and the early lethality phenotype associated with homozygous loss of Lkb1 alone or in combination with Pten. Finally, Pten deletion does not rescue the precocious ductal plate formation reported for Lkb1 deleted livers.
Conclusion:
Our study dissected the functional and molecular crosstalk of PTEN and LKB1 and elucidate key molecular targets for such interaction.
Insights
Loss of tumor suppressors Liver kinase B 1 (LKB1) and PTEN accelerates liver cancer in mice. Their combined loss disrupts liver structure, function, and MRP2 protein regulation, leading to severe defects.
Area of Science:
- Hepatology
- Oncology
- Molecular Biology
Background:
- Liver kinase B 1 (LKB1) and PTEN are critical tumor suppressors regulating the mTOR pathway.
- Loss of either LKB1 or PTEN individually causes liver injury and hepatocarcinoma development.
Purpose of the Study:
- Investigate the crosstalk between LKB1 and PTEN loss in liver development and tumorigenesis.
- Elucidate molecular mechanisms underlying their interaction.
Main Methods:
- Utilized mouse models with genetic alterations in LKB1 and PTEN.
- Analyzed liver structure, function, protein expression, and signaling pathways.
Main Results:
- Haplo-insufficiency of LKB1 accelerates tumor development in PTEN-null mice.
- Combined LKB1 and PTEN loss impairs liver zonal structure formation, glycogen storage, and bilirubin clearance (MRP2 localization).
- Dysregulation of fatty acid synthase and p21 expression observed.
Conclusions:
- Dissected functional and molecular crosstalk between PTEN and LKB1.
- Identified key molecular targets and pathways involved in their interaction during liver development and cancer.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
Canonical Wnt Signaling Pathway